Losigamone (cas 112856-44-7) decreases spontaneous synaptic activity in cultured hippocampal neurons
-
Add time:07/26/2019 Source:sciencedirect.com
Losigamone (cas 112856-44-7) is a new antiepileptic drug with an unknown mechanism of action. Here we report on the effects of losigamone on the synaptic activity in a network of cultured rat hippocampal neurons. Losigamone dose dependently reduced the frequency of spontaneous synaptic events without affecting the mean current amplitude. The drug affected equally the isolated inhibitory as well as excitatory postsynaptic currents. Miniature postsynaptic currents were not altered by losigamone, suggesting that the mechanism of action depends on functional Na+ channels. Consistent with these findings, the drug decreased the frequency of spontaneous action potentials and suppressed repetitive firing of neurons. Thus, losigamone generally depresses synaptic activity in a neuronal network without selectively modulating a specific postsynaptic receptor type. We conclude that losigamone acts via a presynaptic mechanism reducing neuronal excitability.
We also recommend Trading Suppliers and Manufacturers of Losigamone (cas 112856-44-7). Pls Click Website Link as below: cas 112856-44-7 suppliers
Prev:Efficacy and safety of Losigamone (cas 112856-44-7) in partial seizures: a randomized double-blind study
Next:Losigamone (cas 112856-44-7) a putative antiepileptic drug) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Effects of the tetronic acid derivatives AO33 (Losigamone (cas 112856-44-7)) and AO78 on epileptiform activity and on stimulus-induced calcium concentration changes in rat hippocampal slices08/02/2019
- Interactions between two enantiomers of Losigamone (cas 112856-44-7) and conventional antiepileptic drugs in the mouse maximal electroshock model — An isobolographic analysis08/01/2019
- Isobolographic analysis of interactions between Losigamone (cas 112856-44-7) and conventional antiepileptic drugs in the mouse maximal electroshock model07/31/2019
- Chiral high-performance liquid chromatographic analysis of enantiomers of Losigamone (cas 112856-44-7), a new candidate antiepileptic drug07/30/2019
- Effects of XE991, retigabine, Losigamone (cas 112856-44-7) and ZD7288 on kainate-induced theta-like and gamma network oscillations in the rat hippocampus in vitro07/29/2019
- Effects of Losigamone (cas 112856-44-7) on synaptic potentials and spike frequency habituation in rat entorhinal cortex and hippocarnpal CA1 neurones07/28/2019
- Losigamone (cas 112856-44-7) a putative antiepileptic drug07/27/2019
- Efficacy and safety of Losigamone (cas 112856-44-7) in partial seizures: a randomized double-blind study07/25/2019
- The antiepileptic drug Losigamone (cas 112856-44-7) decreases the persistent Na+ current in rat hippocampal neurons07/24/2019